COVID-19 is a fast-moving pandemic. The infection has a mortality rate of 3-6%. Patients with underlying CVD are at higher risk of contracting COVID-19 and have a worse prognosis.
Our experts from Wuhan China and Singapore have shared clinical experiences from frontline China on management of COVID-19 patients with underlying heart disease. Topics include:
Dr. Zhou Ning, Wuhan China
Dr Ling Li Min, Singapore
Dr. Jack Tan, Singapore
Prof Koji Hasegawa, Japan
Dr LAM ho, Hong Kong
Participants can be Cardiologists, ED physicians, Intensivists, Respiratory specialists, Lab specialists, Internists and physicians who are involved in critical care.